CCI Photonics secures £450k to develop rapid diagnostic technology
The funding was backed by investors including Lyva Labs and the Northern Powerhouse Investment Fund II.
£450KSeed
CCI Photonics is a Lancaster University spin out developing diagnostic technology for the rapid detection of infectious diseases and antibiotic susceptibilities.
CCI Photonics has secured £450k in funding from backers including Lyva Labs and the Northern Powerhouse Investment Fund II. The capital will be deployed to develop commercial strategy, support clinical validation studies, and advance the firm's diagnostic prototype. Additional support for the company comes from public bodies and innovation grants.
From the founder
"This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges. The collaboration between Lancaster University and Morecambe Bay NHS Foundation Trust laid the foundation for this innovation."
CA
Carlos Alejandro Meza Ramirez
CEO at CCI Photonics
Use of funds
- 01Continue product development
Investors
Categories
About the company
CP
£450KRaised